Shares of Creo Medical Group PLC (LON:CREO – Get Free Report) rose 24% during mid-day trading on Friday . The stock traded as high as GBX 15.50 and last traded at GBX 14.11. Approximately 1,270,726 shares traded hands during trading, an increase of 61% from the average daily volume of 790,687 shares. The stock had previously closed at GBX 11.38.
Analyst Upgrades and Downgrades
Separately, Shore Capital Group reiterated a “house stock” rating on shares of Creo Medical Group in a report on Thursday, April 16th.
Get Our Latest Analysis on CREO
Creo Medical Group Stock Performance
Creo Medical Group Company Profile
Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.
The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.
Featured Stories
- Five stocks we like better than Creo Medical Group
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo-1200x675.png){kind=logo}
